These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36354205)

  • 41. Molecular mechanism of miR-34b-5p and RNA binding protein HuR binding to lncRNA OIP5-AS1 in colon cancer cells.
    Wang Y; Lin C; Liu Y
    Cancer Gene Ther; 2022 May; 29(5):612-624. PubMed ID: 34021273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long non-coding RNA CASC2 enhances cisplatin sensitivity in oral squamous cell cancer cells by the miR-31-5p/KANK1 axis.
    Wang J; Jia J; Zhou L
    Neoplasma; 2020 Nov; 67(6):1279-1292. PubMed ID: 32787433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LncRNA SH3PXD2A-AS1 facilitates cisplatin resistance in non-small cell lung cancer by regulating FOXM1 succinylation.
    Chen Y; Wu S; Han Y; Shi H; Yuan J; Cui W
    BMC Cancer; 2024 Jul; 24(1):848. PubMed ID: 39020302
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
    Bai T; Liu Y; Li B
    IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LncRNA STXBP5-AS1 suppressed cervical cancer progression via targeting miR-96-5p/PTEN axis.
    Shao S; Wang C; Wang S; Zhang H; Zhang Y
    Biomed Pharmacother; 2019 Sep; 117():109082. PubMed ID: 31212131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D; Zheng Y
    Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of the long non-coding RNA UNC5B-AS1/miR-4455/RSPO4 axis reduces cervical cancer growth in vitro and in vivo.
    Fu J; Zhang Y; Wang M; Hu J; Fang Y
    J Gene Med; 2021 Dec; 23(12):e3382. PubMed ID: 34350661
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137.
    Liang J; Tian XF; Yang W
    World J Gastroenterol; 2020 Apr; 26(13):1474-1489. PubMed ID: 32308348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long non-coding RNA ABHD11-AS1 facilitates the progression of cervical cancer by competitively binding to miR-330-5p and upregulating MARK2.
    Hou S; Zhang X; Yang J
    Exp Cell Res; 2022 Jan; 410(1):112929. PubMed ID: 34793775
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-34b-3p-mediated regulation of STC2 and FN1 enhances chemosensitivity and inhibits proliferation in cervical cancer.
    Jin S; Wang W; Xu X; Yu Z; Feng Z; Xie J; Lv H
    Acta Biochim Biophys Sin (Shanghai); 2024 May; 56(5):740-752. PubMed ID: 38477044
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exosomal lncRNA HEIH promotes cisplatin resistance in tongue squamous cell carcinoma via targeting miR-3619-5p/HDGF axis.
    Wang X; Yu H; Yu Z; Wang D
    Acta Histochem; 2020 Dec; 122(8):151647. PubMed ID: 33130420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Silencing lncRNA FOXD2-AS1 inhibits proliferation, migration, invasion and drug resistance of drug-resistant glioma cells and promotes their apoptosis via microRNA-98-5p/CPEB4 axis.
    Gu N; Wang X; Di Z; Xiong J; Ma Y; Yan Y; Qian Y; Zhang Q; Yu J
    Aging (Albany NY); 2019 Nov; 11(22):10266-10283. PubMed ID: 31770107
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LncRNA PRKCQ-AS1 regulates paclitaxel resistance in triple-negative breast cancer cells through miR-361-5p/PIK3C3 mediated autophagy.
    Zheng S; Fu W; Huang Q; Zhou J; Lu K; Gu J; Ma R; Guo G
    Clin Exp Pharmacol Physiol; 2023 Jun; 50(6):431-442. PubMed ID: 36732923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis.
    Zhao X; Wang J; Zhu R; Zhang J; Zhang Y
    Sci Rep; 2021 Oct; 11(1):21014. PubMed ID: 34697393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression.
    Xu J; Yang B; Wang L; Zhu Y; Zhu X; Xia Z; Zhao Z; Xu L
    Cell Prolif; 2020 Jul; 53(7):e12823. PubMed ID: 32515533
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppression of ZNF205-AS1/EGR4 positive feedback loop attenuates cisplatin resistance of non-small cell lung cancer cells via targeting miR-138-5p/OCT4 pathway.
    Li H; Jin Y; Zhu Y; Shen B; Xu Y
    J Thorac Dis; 2024 Jan; 16(1):296-310. PubMed ID: 38410545
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hsa_circ_0074269-mediated Upregulation of TUFT1 Through miR-485-5p Increases Cisplatin Resistance in Cervical Cancer.
    Chen J; Wu S; Wang J; Sha Y; Ji Y
    Reprod Sci; 2022 Aug; 29(8):2236-2250. PubMed ID: 35075616
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p.
    Hou S; Lin Q; Guan F; Lin C
    J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Knockdown of lncRNA HOXD-AS1 suppresses proliferation, migration and invasion and enhances cisplatin sensitivity of glioma cells by sponging miR-204.
    Zhou H; Ma Y; Zhong D; Yang L
    Biomed Pharmacother; 2019 Apr; 112():108633. PubMed ID: 30784927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SP1-induced lncRNA FOXD3-AS1 contributes to tumorigenesis of cervical cancer by modulating the miR-296-5p/HMGA1 pathway.
    Ma WG; Shi SM; Chen L; Lou G; Feng XL
    J Cell Biochem; 2021 Feb; 122(2):235-248. PubMed ID: 32959937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.